These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7660645)

  • 61. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
    Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis.
    Nelson JL; Hughes KA; Smith AG; Nisperos BB; Branchaud AM; Hansen JA
    N Engl J Med; 1993 Aug; 329(7):466-71. PubMed ID: 8332151
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alloimmunization against well defined polymorphic major histocompatibility or class I MHC transfected L cells antigens can prevent poly IC induced fetal death in mice.
    Menu E; Chaouat G; Kinsky R; Delage G; Kapovic M; Thang MN; Jaulin C; Kourilsky P; Wegmann TG
    Am J Reprod Immunol; 1995 Feb; 33(2):200-11. PubMed ID: 7646771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
    Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
    Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
    Tantalo V; Rossi E; Gianotti GA; Morotti R; Zuliani G; Buscaglia M; Galligani M
    Ann Ostet Ginecol Med Perinat; 1990; 111(5):321-5. PubMed ID: 2092607
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Do red cell alloantibodies continue to challenge breast fed babies?
    Rasalam JE; Kumar S; Amalraj P; Bal HS; Mathai J; Kumar M; Sridhar S; Daniel D
    Transfus Med; 2020 Aug; 30(4):281-286. PubMed ID: 32083382
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The modulation of human aortic endothelial cell ICAM-1 (CD-54) expression by serum containing high titers of anti-HLA antibodies.
    Hosenpud JD; Shipley GD; Morris TE; Hefeneider SH; Wagner CR
    Transplantation; 1993 Feb; 55(2):405-11. PubMed ID: 7679530
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D; Lazarus AH
    Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IgG subclasses and Gm allotypes of anti-D antibodies during pregnancy: correlation with the gravity of the fetal disease.
    Parinaud J; Blanc M; Grandjean H; Fournie A; Bierme S; Pontonnier G
    Am J Obstet Gynecol; 1985 Apr; 151(8):1111-5. PubMed ID: 3920914
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Haemolytic disease of the newborn probably due to anti-ELO, an antibody to a low frequency red cell antigen.
    Ford DS; Stern DA; Hawksworth DN; Lubenko A; Pope JM; Chana HS; Better PJ
    Vox Sang; 1992; 62(3):169-72. PubMed ID: 1609518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rhesus haemolytic disease.
    Whittle MJ
    Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
    [No Abstract]   [Full Text] [Related]  

  • 74. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Severe hemolytic disease of the newborn due to anti-Js(b).
    Gordon MC; Kennedy MS; O'Shaughnessy RW; Waheed A
    Vox Sang; 1995; 69(2):140-1. PubMed ID: 8585197
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Serological conflict: relation between antibody titer, Liley's zone and the condition of the fetus and newborn infant].
    Czeszyńska M; Zieliński M; Czajkowski Z; Hnatyszyn G
    Acta Haematol Pol; 1991; 22(2):279-89. PubMed ID: 1841500
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Direct antiglobulin reaction in ABO-haemolytic disease of the newborn.
    Romano EL; Hughes-Jones NC; Mollison PL
    Br Med J; 1973 Mar; 1(5852):524-6. PubMed ID: 4540300
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transfer of anti-HLA-DR antibodies from the mother to the child. Are DR antigens expressed on the placenta?
    Tongio MM; Werneburg B; Mayer S
    Tissue Antigens; 1983 Jul; 22(1):24-8. PubMed ID: 6577694
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Auto-anti-D blocking D determinants on red cells in pregnancy.
    Kuśnierz-Alejska G; Bugajna I; Seyfried H
    Mater Med Pol; 1990; 22(1):17-20. PubMed ID: 1706816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Results of tests with different cellular bioassays in relation to severity of RhD haemolytic disease. Report from nine collaborating laboratories.
    Vox Sang; 1991; 60(4):225-9. PubMed ID: 1926829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.